Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
《公司業績》泰凌醫藥全年虧損擴大至1.44億元人民幣

2024-04-01T  
泰凌醫藥與環球新常態基訂立合作備忘

2023-10-10T  
泰凌醫藥 : 蘇州第壹製藥重整已確認未償還債務逾6億元人幣

2023-09-15T  
泰凌醫藥折讓13.79%配股 籌淨額2,280萬元

2023-09-03T  
《公司業績》泰凌醫藥半年虧損收窄至561.2萬人幣

2023-09-01T  
《瑞銀窩輪》比亞迪(01211)發布上半年盈喜 看好留意比迪認購(14342)

2023-07-18T  
泰凌醫藥(01011.HK):與債權人積極商討 或會重整蘇州第壹製藥

2023-05-02T  
《公司業績》泰凌醫藥(01011.HK)去年虧損收窄至6,641萬元人民幣

2023-04-03T  
《公司業績》泰凌醫藥(01011.HK)中期虧損擴至2,824萬人民幣

2022-09-01T  
泰凌醫藥(01011.HK)獲授Orticumab於大中華等地商業化獨家永久許可

2022-06-22T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.